Search

everythinglearnresearchcommunity

for

Search:↓

A 73-year-old woman's unusual hair loss and growth led to the discovery of a rare condition causing too much testosterone, which improved after her ovaries were removed.

Evaluating various physical and health factors helps diagnose polycystic ovarian syndrome (PCOS).

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

A woman with high testosterone and an adrenal nodule had an ovarian tumor causing her symptoms, which improved after the tumor was removed.

The document concludes that Polycystic Ovary Syndrome is a commonly underdiagnosed hormonal disorder in women, diagnosed by specific criteria.

A woman's masculine symptoms were caused by a rare tumor in her left ovary, which was found using a special blood test.

These ovarian conditions cause high testosterone levels.

A new hyaluronan-based biomatrix successfully supports the growth of mouse ovarian follicles, producing healthy eggs.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

PCOS affects quality of life most in infertility, and treatments vary by weight.

Women with different PCOS types have similar fertility treatment results.

Ovarian thecomas can cause virilization in postmenopausal women and are treated with surgery.

PCOS may be influenced by factors in the blood, not just the ovaries.

A special blood test helped find the overactive ovary in a teen with PCOS, and removing that ovary improved her condition.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Women with PCOS have distinct retinal changes compared to healthy women.

Surgery removed ovarian tumors, normalizing testosterone and improving symptoms.

Early detection of ovarian steroid cell tumors is crucial to prevent lasting symptoms.

Ovarian stromal hyperplasia can cause high testosterone in postmenopausal women and is treated by removing the ovaries.

Women with PCOS have hormonal imbalances and increased central obesity, highlighting the need for early detection and management.

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

The definition of Polycystic Ovary Syndrome may change with new research, and careful screening is key for managing the condition.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Women with PCOS have different body composition and some metabolic differences compared to healthy women.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.